200484-11-3 | CHS-828 (Catalog# : 100904)CHS-828, also known as GMX-1778, is a potent and selective NAMPT inhibitor. CHS-828 inhibits cellular synthesis of NAD. CHS 828 kill tumour cells by inhibiting the nuclear factor
288383-20-0 | Cediranib (Catalog# : 52779)Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM, also inhibits Flt1/4 with IC50 of 5 nM/3 nM, similar activity against c-Kit and PDGFR, 36-, 110
285986-88-1 | CCG-1423 (Catalog# : 52502)CCG-1423 is a novel inhibitor of RhoA/C-mediated gene transcription that is capable of inhibiting invasion of PC-3 prostate cancer cells in a Matrigel model of metastasis.
244767-67-7 | Dapivirine (Catalog# : 52549)Dapivirine(TMC 120, TMC 120 R147681) is a NNRTI for HIV reverse transcriptase with IC50 of 24 nM, inhibits a broad panel of HIV-1 isolates from different classes, inclucing a wid
229476-53-3 | EBE-A22 (Catalog# : 179831)EBE-A22 is a derivative of PD 153035. EBE-A22, has no effect on EGF-R TK but maintains a high cytotoxic profile. EBE-A22 binds to DNA and behave as typical intercalating agents.
202409-33-4 | Etoricoxib (Catalog# : 82709)Etoricoxib selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of 1.1 0.1 M for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an